Recall Z-0614-2013— Roche Molecular Systems, Inc.

Class II · Terminated

Class II FDA medical device recall by Roche Molecular Systems, Inc., initiated 2012-10-11, terminated 2013-09-11. FDA's recall record names no specific 510(k) clearance for this event. Product: COBAS AmpliPrep Instrument (CAP) with AMPLILINK (AL) Software v.3.3.5 Automated sample processing instrument used with CAP/CA and CAP/CTM. Roche Molecular Systems, Inc. 1080 US Highway 202 South Branchburg, NJ 08876 USA Made in Switzerland. Reason: Certain COBAS AmpliPrep instruments using AMPILINK software v.3.3.4 had the sample clot detection flagging feature disabled during quality control release resulting in samples that may not be flagged as having clots..

Recalling firm
Roche Molecular Systems, Inc.
Classification
Class II
Status
Terminated
Initiated
2012-10-11
Terminated
2013-09-11
Firm location
Branchburg, NJ, United States

Product description

COBAS AmpliPrep Instrument (CAP) with AMPLILINK (AL) Software v.3.3.5 Automated sample processing instrument used with CAP/CA and CAP/CTM. Roche Molecular Systems, Inc. 1080 US Highway 202 South Branchburg, NJ 08876 USA Made in Switzerland

Reason for recall

Certain COBAS AmpliPrep instruments using AMPILINK software v.3.3.4 had the sample clot detection flagging feature disabled during quality control release resulting in samples that may not be flagged as having clots.

Data sourced from openFDA. This site is unofficial and independent of the FDA.